[go: up one dir, main page]

BRPI0416201A - métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis - Google Patents

métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis

Info

Publication number
BRPI0416201A
BRPI0416201A BRPI0416201-3A BRPI0416201A BRPI0416201A BR PI0416201 A BRPI0416201 A BR PI0416201A BR PI0416201 A BRPI0416201 A BR PI0416201A BR PI0416201 A BRPI0416201 A BR PI0416201A
Authority
BR
Brazil
Prior art keywords
purification
methods
pertussis toxin
peptides
usable
Prior art date
Application number
BRPI0416201-3A
Other languages
English (en)
Inventor
Andreas Jungbluth
Eberhard Schneider
Peter Wagner
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of BRPI0416201A publication Critical patent/BRPI0416201A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODOS PARA PURIFICAçãO DE TOXINA COQUELUCHE E PEPTìDIOS NELES UTILIZáVEIS". A presente invenção se refere a reagentes e métodos para a purificação de toxina Pertussis (PT).
BRPI0416201-3A 2003-11-20 2004-11-18 métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis BRPI0416201A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52388103P 2003-11-20 2003-11-20
PCT/US2004/038700 WO2005051985A2 (en) 2003-11-20 2004-11-18 Methods for purifying pertussis toxin and peptides useful therefor

Publications (1)

Publication Number Publication Date
BRPI0416201A true BRPI0416201A (pt) 2006-12-26

Family

ID=34632841

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416201-3A BRPI0416201A (pt) 2003-11-20 2004-11-18 métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis

Country Status (11)

Country Link
US (3) US8299210B2 (pt)
EP (1) EP1692313A2 (pt)
JP (2) JP4885729B2 (pt)
KR (2) KR101320905B1 (pt)
CN (1) CN1906307B (pt)
AU (1) AU2004292547B9 (pt)
BR (1) BRPI0416201A (pt)
CA (1) CA2546343A1 (pt)
IL (3) IL175630A (pt)
WO (1) WO2005051985A2 (pt)
ZA (1) ZA200604081B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1692313A2 (en) * 2003-11-20 2006-08-23 Sanofi Pasteur Inc. Methods for purifying pertussis toxin and peptides useful therefor
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
SI2379096T1 (sl) 2008-12-19 2020-03-31 Baxalta GmbH Zaviralci TFPI in postopki uporabe
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
CA2793465C (en) * 2010-03-19 2022-06-14 Baxter International Inc. Tfpi inhibitors and methods of use
NZ724133A (en) 2012-03-21 2020-07-31 Baxalta Inc Tfpi inhibitors and methods of use
CN105974122B (zh) * 2016-05-04 2018-09-28 华东医药（杭州）基因科技有限公司 一种检测外泌体gpc1蛋白的方法
CN113933438B (zh) * 2021-11-11 2023-11-10 威海华洋药业有限公司 一种紫芪克咳口服液的含量测定方法及制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970162A (en) * 1985-11-13 1990-11-13 The United States Of America As Represented By The Department Of Health And Human Services Human-mouse hybrid cell line expressing monocyte-macrophage properties
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5244657A (en) * 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5221618A (en) * 1987-11-24 1993-06-22 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
US6696065B1 (en) * 1995-05-04 2004-02-24 Aventis Pastuer Limited Acellular pertussis vaccines and methods of preparation thereof
NZ306391A (en) * 1995-05-04 1999-03-29 Connaught Lab Acellular pertussis vaccines comprising purified toxin, filamentous haemagglutinin, pertactin and fimbrial agglutinogins
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
AU757955B2 (en) * 1998-08-17 2003-03-13 Bristol-Myers Squibb Company Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
ES2280131T3 (es) * 1998-12-02 2007-09-01 Adnexus Therapeutics, Inc. Fusiones de adn-proteina y utilizaciones de las mismas.
JP2003500081A (ja) * 1999-06-01 2003-01-07 フィロス インク． ５’核酸−タンパク質結合体の生成法
HK1045334A1 (zh) * 1999-07-27 2002-11-22 Phylos, Inc. 缩氨酸受体结紮方法
CA2382545C (en) * 1999-08-27 2013-08-13 Phylos, Inc. Methods for encoding and sorting in vitro translated proteins
US7115284B2 (en) * 2003-08-11 2006-10-03 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis
EP1692313A2 (en) * 2003-11-20 2006-08-23 Sanofi Pasteur Inc. Methods for purifying pertussis toxin and peptides useful therefor
WO2007038619A2 (en) * 2005-09-27 2007-04-05 Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof
US20080241281A1 (en) * 2007-03-29 2008-10-02 Texas Tech University System Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development

Also Published As

Publication number Publication date
CA2546343A1 (en) 2005-06-09
AU2004292547B9 (en) 2012-04-26
KR101337320B1 (ko) 2013-12-06
KR20060129195A (ko) 2006-12-15
IL205274A0 (en) 2011-07-31
IL205275A0 (en) 2011-07-31
CN1906307A (zh) 2007-01-31
AU2004292547B2 (en) 2011-12-22
IL175630A (en) 2015-10-29
WO2005051985A3 (en) 2005-09-29
US20160032258A1 (en) 2016-02-04
US20090215113A1 (en) 2009-08-27
WO2005051985A2 (en) 2005-06-09
EP1692313A2 (en) 2006-08-23
US8299210B2 (en) 2012-10-30
IL175630A0 (en) 2006-09-05
HK1099655A1 (en) 2007-08-17
KR101320905B1 (ko) 2013-11-06
JP2011173919A (ja) 2011-09-08
IL205275A (en) 2013-07-31
US9145445B2 (en) 2015-09-29
KR20120117942A (ko) 2012-10-24
JP5379187B2 (ja) 2013-12-25
ZA200604081B (en) 2007-09-26
JP4885729B2 (ja) 2012-02-29
JP2008504802A (ja) 2008-02-21
AU2004292547A1 (en) 2005-06-09
US20140187742A1 (en) 2014-07-03
IL205274A (en) 2013-07-31
CN1906307B (zh) 2011-08-24

Similar Documents

Publication Publication Date Title
DE60226797D1 (de) Instrument zum Einbringen von Befestigungselementen für Transplantate
BR122018016045B8 (pt) proteína variante otimizada
BRPI0314814B8 (pt) anticorpo compreendendo uma variante de fc
DK1543002T3 (da) Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
BRPI0412667A (pt) sìntese regiosseletiva de cci - 779
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
BRPI0311516A2 (pt) xampu de condicionamento que contém amino silicone
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20042159L (no) Cellokulturprosess
BR0306905A (pt) Vacinas de flavivìrus
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
CY1113083T1 (el) Ασβεστιολυτικες ενωσεις
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
SE0301650D0 (sv) Novel compounds
NO20043107L (no) Bronnsementeringsbestanddeler for kalde omgivelser
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
DE60231875D1 (de) Kartographisches bildsyntheseverfahren
NO20033921L (no) Inhibitor av monoaminopptak
DE50204476D1 (de) Gasfeder
NO20061125L (no) Fremstilling av somatostatinpeptider
DE60124148D1 (de) Kalzilytische verbindungen
DE50310498D1 (de) Elastisches Lager

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]